APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
51 hedge funds and large institutions have $207M invested in Aptose Biosciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 22
56% less call options, than puts
Call options by funds: $578K | Put options by funds: $1.3M
Holders
51
Holding in Top 10
6
Calls
$578K
Puts
$1.3M
Top Buyers
| 1 | +$15.1M | |
| 2 | +$14.6M | |
| 3 | +$9.16M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$6.08M |
| 5 |
Goldman Sachs
New York
|
+$3.88M |
Top Sellers
| 1 | -$5.72M | |
| 2 | -$5.51M | |
| 3 | -$4.37M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.65M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$3.45M |